Publication:
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry.

Loading...
Thumbnail Image

Date

2022-06-03

Authors

Quiroga, Borja
Ortiz, Alberto
Cabezas-Reina, Carlos Jesus
Ruiz Fuentes, Maria Carmen
Lopez Jimenez, Veronica
Zarraga Larrondo, Sofia
Toapanta, Nestor
Molina Gomez, Maria
de Sequera, Patricia
Sanchez-Alvarez, Emilio

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Kidney replacement therapy (KRT) conferred a high risk for coronavirus disease 2019 (COVID-19) related mortality early in the pandemic. We evaluate the presentation, treatment and outcomes of COVID-19 in patients on KRT over time during the pandemic. This registry-based study involved 6080 dialysis and kidney transplant (KT) patients with COVID-19, representing roughly 10% of total Spanish KRT patients. Epidemiology, comorbidity, infection, vaccine status and treatment data were recorded, and predictors of hospital admission, intensive care unit (ICU) admission and mortality were evaluated. Vaccine introduction decreased the number of COVID-19 cases from 1747 to 280 per wave. Of 3856 (64%) COVID-19 KRT patients admitted to the hospital, 1481/3856 (38%) were admitted during the first of six waves. Independent predictors for admission included KT and the first wave. During follow-up, 1207 patients (21%) died, 500/1207 (41%) during the first wave. Among vaccinated patients, mortality was 19%, mostly affecting KT recipients. Overall, independent predictors for mortality were older age, disease severity (lymphopaenia, pneumonia) and ICU rejection. Among patient factors, older age, male sex, diabetes, KT and no angiotensin receptor blockers (ARB) were independent predictors of death. In KT recipients, individual immunosuppressants were independent predictors of death. Over time, patient characteristics evolved and in later pandemic waves, COVID-19 was mainly diagnosed in vaccinated KT recipients; in the few unvaccinated dialysis patients, ICU admissions increased and mortality decreased (28% for the first wave and 16-22% thereafter). The clinical presentation and outcomes of COVID-19 during the first wave no longer represent COVID-19 in KRT patients, as the pandemic has become centred around vaccinated KT recipients. Vaccines lowered the incidence of diagnosed COVID-19 and mortality. However, mortality remains high despite increased access to ICU care.

Description

MeSH Terms

Humans
Male
Kidney Transplantation
Angiotensin Receptor Antagonists
Incidence
Follow-Up Studies

DeCS Terms

Angiotensin Receptor Antagonists
Comorbidity
Death
Dialysis
Immunosuppressive Agents

CIE Terms

Keywords

COVID-19, SARS-CoV-2, dialysis, kidney transplant, mortality

Citation

Quiroga B, Ortiz A, Cabezas-Reina CJ, Ruiz Fuentes MC, López Jiménez V, Zárraga Larrondo S, Toapanta N, Molina Gómez M, de Sequera P, Sánchez-Álvarez E; Spanish COVID-19 KRT Registry collaborative group. Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry. Clin Kidney J. 2022 Jun 3;15(9):1685-1697